Genzymes CSR Dilemma Case Study Example | Topics and Well Written Essays - 750 words

Genzymes CSR Dilemma - Case Study ExampleAll this point pop to a dire need in the market for intensive research and development of a impertinentlyfound drug for T.B. Genzyme although incapacitated with scarce resources has been able to create good partnership with The TB Alliance partnership. The Global Alliance for TB Drug Development provided a highly skilled biotechnology smashed. The reenforcement of the partnership by the Gates and Rockefeller foundation provides a sure way of capital funding for the inflexible and expensive venture into the development of an effective drug.Outsourcing the research to pharmaceutical giants such as Bayer and GlaxoSmithKline ensures that take away machinery and skill is put into play in the development. With Genzyme vast infiltration into the developing countries, potential targets could be sourced for screening although it would require sufficient funding which was possible with the funding by the two foundations.In the current consider ation of HAND, Genzyme aims at maximizing returns as much as helping people suffering from common treatable alone neglected highly infectious diseases. To do this, Termeer should consider the potential for the firms resources and capabilities to achieve warring advantage over their competitors.Termeer should consider using the Resource- Based Model of Above Average Returns (Hitt, Ireland, and Hoskisson 17). This model assumes that each organization should develop its own resources that should be unique into capabilities. These capabilities arise out of integration of resources into a delegate that should be dynamically managed.These resources and capabilities should serve as a competitive advantage for the firm. This brews core competencies that enable the firm to produce products that are unique and non-imitable in the market place by competitors to give a supplement to the returns.Through practice and continued use of these resources, the firm creates a strong capability to d evelop new products that